| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/03/2011 | US20110027901 Methods and devices for detecting the presence of an analyte in a sample |
| 02/03/2011 | US20110027900 Thiol quantitation assays and related methods |
| 02/03/2011 | US20110027899 Hazardous chemicals detector & methods of use thereof |
| 02/03/2011 | US20110027898 Methods and articles for strand-specific polynucleotide detection with conjugated polymers |
| 02/03/2011 | US20110027897 Biomarker to Measure Drug Efficacy in Enteropathic Disease |
| 02/03/2011 | US20110027896 Chromophore and polymer capable of detecting the presence of various neurotoxins and method of use |
| 02/03/2011 | US20110027895 Determination method of magnesium content in aluminium alloy |
| 02/03/2011 | US20110027894 Biomarkers for detection of early- and late-stage endometrial cancer |
| 02/03/2011 | US20110027893 Method and apparatus for automated determining of chemical oxygen demand of a liquid sample |
| 02/03/2011 | US20110027883 Rna interference mediating small rna molecules |
| 02/03/2011 | US20110027860 Gene encoding chondroitinase abc and uses therefor |
| 02/03/2011 | US20110027819 Use of sfrp-3 in the assessment of heart failure |
| 02/03/2011 | US20110027814 BRCA1 function-based cellular assays |
| 02/03/2011 | US20110027813 Compositions for Binding to Assay Substrata and Methods of Using |
| 02/03/2011 | US20110027812 Assay for antibodies to mycobacterium paratuberculosis |
| 02/03/2011 | US20110027811 Assay system for the assessment of oncogenicity, tumor progression, and treatment efficacy |
| 02/03/2011 | US20110027810 Chimeric recombinant antigens of toxoplasma gondii |
| 02/03/2011 | US20110027809 Method for evaluation of degree of malignancy of tumor cell |
| 02/03/2011 | US20110027808 Methods and kits for detecting tumor-specific fusion proteins |
| 02/03/2011 | US20110027807 Protein specific to pancreatic beta cells in islets of langerhans and applications thereof |
| 02/03/2011 | US20110027806 Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis |
| 02/03/2011 | US20110027805 Acpl-related assays |
| 02/03/2011 | US20110027804 Immune system modeling devices and methods |
| 02/03/2011 | US20110027803 Compositions and Methods for Maintenance of Fluid Conducting and Containment Systems |
| 02/03/2011 | US20110027802 Methods and Kits for Separation and Detection of Proteins in Biological Samples |
| 02/03/2011 | US20110027801 EphA KINASE CANCER DIAGNOSTIC |
| 02/03/2011 | US20110027800 Derivatives of 1,2-dihydro-7-hydroxyquinolines Containing Fused Rings |
| 02/03/2011 | US20110027797 Method for the Diagnosis of Higher- and Lower-Grade Astrocytoma Using Biomarkers and Diagnostic Kit Thereof |
| 02/03/2011 | US20110027795 Cell processing and/or enrichment methods |
| 02/03/2011 | US20110027793 Kit for measuring in vivo mutation frequency at an endogenous gene locus |
| 02/03/2011 | US20110027785 Method for determining susceptibility of individuals to polyphenols |
| 02/03/2011 | US20110027781 System for Autonomous Monitoring of Bioagents |
| 02/03/2011 | US20110027773 Mass spectrometric methods for detecting mutations in a target nucleic acid |
| 02/03/2011 | US20110027771 Methods and compositions for cell stabilization |
| 02/03/2011 | US20110027614 Corrosion resistant object with alloying zone |
| 02/03/2011 | US20110027397 Methods of treating autism spectrum disorders and compositions for same |
| 02/03/2011 | US20110027321 Chlamydia Vaccine Comprising HtrA Polypeptides |
| 02/03/2011 | US20110027314 Influenza Vaccines Containing Hemagglutinin and Matrix Proteins |
| 02/03/2011 | US20110027299 Melanoma antigens and their use in diagnostic and therapeutic methods |
| 02/03/2011 | US20110027297 Methods Involving MS4A12 and Agents Targeting MS4A12 for Therapy, Diagnosis and Testing |
| 02/03/2011 | US20110027291 Methods, systems and products for predicting response of tumor cells to a therapeutic agent and treating a patient according to the predicted response |
| 02/03/2011 | US20110027285 Methods and agents modulating upa/upar activity |
| 02/03/2011 | US20110027283 Methods for diagnosing and treating cancers |
| 02/03/2011 | US20110027281 Single domain antibodies directed against tumor necrosis factor-alpha and uses therefor |
| 02/03/2011 | US20110027277 Predictive marker for topoisomerase i inhibitors |
| 02/03/2011 | US20110027261 Anti-hepcidin antibodies and uses thereof |
| 02/03/2011 | US20110027254 Compositions and methods for treating gaucher disease |
| 02/03/2011 | US20110027248 Sugar Chain-Related Gene and Use Thereof |
| 02/03/2011 | US20110027187 Therapeutic or prophylactic agent, detection method and detection agent for metabolic syndrome, and method for screening of candidate compound for therapeutic agent for metabolic syndrome |
| 02/03/2011 | US20110027185 Methods of Screening for Anti-Angiogenic Compounds |
| 02/03/2011 | US20110027184 Protein c pathway associated polymorphisms as response predictors to activated protein c or protein c-like compound administration |
| 02/03/2011 | US20110027183 Hydrophobic Modified Pres-Derived Peptides of Hepatitis B Virus (HBV) and Their Use as Vehicles for the Specific Delivery of Compounds to the Liver |
| 02/03/2011 | US20110027182 Substance for obtaining highly effective tumor medications as well as a process |
| 02/03/2011 | US20110027180 Detection and treatment of prostate cancer |
| 02/03/2011 | US20110027177 Inhibition of angiogenesis |
| 02/03/2011 | US20110027173 Ephrin type-a receptor 10 protein |
| 02/03/2011 | US20110026009 Surface Mapping by Optical Manipulation of Particles in Relation to a Functionalized Surface |
| 02/03/2011 | US20110024690 Curable compositions containing color indicators for indicating the curing progress |
| 02/03/2011 | US20110024308 Immunoassay |
| 02/03/2011 | US20110024307 Analyte sensor |
| 02/03/2011 | US20110024306 Method and device for analyzing lipid component contained in serum |
| 02/03/2011 | US20110023586 Water analysis sensor arrangement |
| 02/03/2011 | US20110023575 Non-invasive sensor calibration device |
| 02/03/2011 | DE102009035502A1 Verfahren und Vorrichtung zur Erfassung der Bewegung und Anlagerung von Zellen und Partikeln an Zell-, Gewebe- und Implantatschichten bei der Simulation von Flussbedingungen Method and apparatus for detecting the movement and deposition of cells and particles in cell, tissue and implant layers in the simulation of flow conditions |
| 02/03/2011 | DE102009028165A1 Verfahren und Vorrichtung zur automatisierten Bestimmung des chemischen Sauerstoffbedarfs einer Flüssigkeitsprobe Method and apparatus for automated determination of the chemical oxygen demand of a liquid sample |
| 02/03/2011 | DE102009022473B3 Sampling system for use in sample reprocessing device for sampling biological sample, during analytical examination, has permanent magnets arranged such that distal section of pin is fixed at wall of container so that fluid is sucked |
| 02/03/2011 | CA2769747A1 Device for detection of antigens and uses thereof |
| 02/03/2011 | CA2769518A1 Dual variable domain immunoglobulins and uses thereof |
| 02/03/2011 | CA2769462A1 Serum markers predicting clinical response to anti-tnf.alpha. antibodies in patients with psoriatic arthritis |
| 02/03/2011 | CA2769308A1 Inhibition of tumor metastasis using bv8- or g-csf-antagonists |
| 02/03/2011 | CA2769243A1 Use of mimecan in the assessment of heart failure |
| 02/03/2011 | CA2769006A1 Method and apparatus for conducting an assay |
| 02/03/2011 | CA2768528A1 Method for detecting and identifying a variant c. difficile strain in a sample |
| 02/03/2011 | CA2768330A1 Non-invasive in vivo optical imaging method |
| 02/03/2011 | CA2768086A1 Hydroxy fatty acid compounds and uses thereof for disease treatment and diagnosis |
| 02/03/2011 | CA2767950A1 Improvements relating to sensor devices |
| 02/03/2011 | CA2767763A1 Method for predicting the likelihood of an onset of an inflammation associated organ failure |
| 02/03/2011 | CA2766271A1 Alloyed metal colloid |
| 02/02/2011 | EP2280286A1 Method of using cytokine assays to diagnose, treat, and evaluate systemic lupus erythematosus |
| 02/02/2011 | EP2280285A1 Method of using cytokine assays to diagnose, treat, and evaluate inflammatory and autoimmune diseases |
| 02/02/2011 | EP2280284A1 Biosensor |
| 02/02/2011 | EP2280283A1 Labeled cells for use as an internal functional control in rare cell detection assays |
| 02/02/2011 | EP2280282A1 Methods of detecting Lp-PLA2 activity |
| 02/02/2011 | EP2280281A1 5-fluoro-uracil immunoassay |
| 02/02/2011 | EP2280280A1 5-fluoro-uracil immunoassay |
| 02/02/2011 | EP2280279A1 Method for evaluation of function of phagocyte |
| 02/02/2011 | EP2280278A1 Blood analyzer, blood analysis method and hemolytic agent |
| 02/02/2011 | EP2280277A1 Biosensor with flow channel |
| 02/02/2011 | EP2280276A2 Method and apparatus for rapid electrochemical analysis |
| 02/02/2011 | EP2280275A2 Reduction of pressure induced temperature influence on the speed of sound in a gas |
| 02/02/2011 | EP2280274A2 Acousto-mechanical detection system |
| 02/02/2011 | EP2280272A1 Method for applying NMR for ligand discovery or as a drug screening tool |
| 02/02/2011 | EP2280268A1 Multi-array, multi-specific electrochemiluminescence testing |
| 02/02/2011 | EP2280267A2 Device and method for detecting molecular interactions |
| 02/02/2011 | EP2280083A1 Nucleid acid ligand diagnostic biochip |
| 02/02/2011 | EP2280077A1 Method for detection of cancer cell induced by hpv, method for determination concerning whether or not tissue is in later stage of severe dysplasia, and primer set and kit for use in the methods |
| 02/02/2011 | EP2280071A2 Haemophilus influenzae antigens and corresponding DNA fragments |
| 02/02/2011 | EP2280067A2 Novel genes encoding novel proteolytic enzymes |
| 02/02/2011 | EP2280053A1 Circularly polarized light-emitting nanoparticle |
| 02/02/2011 | EP2280052A1 Fluorescent compounds for the diagnosis of infections, production method, and applications thereof |